Published in BMC Public Health on September 02, 2010
Metabolic syndrome prevalence according to ATP III and IDF criteria and related factors in Turkish adults. Arch Med Sci (2013) 0.99
Health services utilization, work absenteeism and costs of pandemic influenza A (H1N1) 2009 in Spain: a multicenter-longitudinal study. PLoS One (2012) 0.98
Prevalence of metabolic syndrome: association with risk factors and cardiovascular complications in an urban population. PLoS One (2014) 0.90
JIS definition identified more Malaysian adults with metabolic syndrome compared to the NCEP-ATP III and IDF criteria. Biomed Res Int (2013) 0.86
Blood pressure relation to body composition and age: analysis of a nurse-led investigation and consultation program. Med Sci Monit (2013) 0.86
Ethnic disparities in metabolic syndrome in malaysia: an analysis by risk factors. Metab Syndr Relat Disord (2011) 0.82
Gut microbiota-based translational biomarkers to prevent metabolic syndrome via nutritional modulation. FEMS Microbiol Ecol (2013) 0.81
The importance of local criteria in the diagnosis of metabolic syndrome in Saudi Arabia. Ther Adv Endocrinol Metab (2013) 0.80
Effects of eight weeks of aerobic interval training and of isoinertial resistance training on risk factors of cardiometabolic diseases and exercise capacity in healthy elderly subjects. Oncotarget (2015) 0.79
Effects of a 12-Week Hatha Yoga Intervention on Metabolic Risk and Quality of Life in Hong Kong Chinese Adults with and without Metabolic Syndrome. PLoS One (2015) 0.79
Metabolic syndrome in hypertensive patients: An unholy alliance. World J Cardiol (2014) 0.78
Economic aspects of hypertension treatment in Poland. Arch Med Sci (2013) 0.76
Metabolic syndrome is associated with left ventricular dilatation in primary hypertension. J Hum Hypertens (2015) 0.75
Human Bisphenol A Exposure and the "Diabesity Phenotype". Dose Response (2015) 0.75
Factors associated with metabolic syndrome and related medical costs by the scale of enterprise in Korea. Ann Occup Environ Med (2013) 0.75
Prevalence of metabolic syndrome in the clinical practice of general medicine in Italy. Cardiovasc Diagn Ther (2015) 0.75
An update on psoriasis and metabolic syndrome: A meta-analysis of observational studies. PLoS One (2017) 0.75
A cross-sectional analysis of the association between age and gender and prescribed minimum benefit chronic disease list conditions among South Africans with concomitant hypertension, diabetes and dyslipidaemia. Afr Health Sci (2017) 0.75
Efficacy and Tolerability of Antihypertensive Drugs in Diabetic and Nondiabetic Patients. J Pharm Bioallied Sci (2017) 0.75
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA (2003) 97.28
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation (2002) 76.93
Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care (1993) 17.66
Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care (2001) 14.03
Global burden of blood-pressure-related disease, 2001. Lancet (2008) 11.09
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2007) 9.43
Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care (2005) 7.05
Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis. Lancet (2007) 6.80
Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation (2003) 5.70
Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med (2006) 4.69
Obesity prevalence from a European perspective: a systematic review. BMC Public Health (2008) 3.67
Optimal treatment of obesity-related hypertension: the Hypertension-Obesity-Sibutramine (HOS) study. Circulation (2007) 3.59
Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: daily life blood pressure, cardiac damage, and prognosis. Hypertension (2006) 2.65
Revealing the cost of Type II diabetes in Europe. Diabetologia (2002) 2.52
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. Blood Press (2009) 1.98
The economic burden associated with osteoarthritis, rheumatoid arthritis, and hypertension: a comparative study. Ann Rheum Dis (2004) 1.92
Long-term cost and life-expectancy consequences of hypertension. J Hypertens (1998) 1.68
Pandemic obesity in Europe. BMJ (2006) 1.50
Mechanisms of hypertension in the cardiometabolic syndrome. J Hypertens (2009) 1.50
Prognostic value of the metabolic syndrome in essential hypertension. J Am Coll Cardiol (2004) 1.47
Harmonizing the definition of the metabolic syndrome: comparison of the criteria of the Adult Treatment Panel III and the International Diabetes Federation in United States American and European populations. Am J Cardiol (2007) 1.38
Discontinuation of and changes in drug therapy for hypertension among newly-treated patients: a population-based study in Italy. J Hypertens (2008) 1.23
Different impact of the metabolic syndrome on left ventricular structure and function in hypertensive men and women. Hypertension (2006) 1.13
Which is more important for the efficiency of hypertension treatment: hypertension stage, type of drug or therapeutic compliance? J Hypertens (2001) 1.10
Obesity: impact of cardiovascular disease. Circulation (1998) 1.06
Pharmacoeconomics of antihypertensive drug treatment: an analysis of how long patients remain on various antihypertensive therapies. J Clin Hypertens (Greenwich) (2004) 1.04
Excess morbidity and cost of failure to achieve targets for blood pressure control in Europe. Blood Press (2002) 1.03
Increased prevalence of metabolic syndrome in uncontrolled hypertension across Europe: the Global Cardiometabolic Risk Profile in Patients with hypertension disease survey. J Hypertens (2008) 1.00
The metabolic syndrome in hypertension: European society of hypertension position statement. J Hypertens (2008) 0.99
The effect of discontinuation of antihypertensives on the risk of acute myocardial infarction and stroke. Curr Med Res Opin (2008) 0.99
Prevalence of the metabolic syndrome in patients with hypertension treated in general practice in Spain: an assessment of blood pressure and low-density lipoprotein cholesterol control and accuracy of diagnosis. J Cardiometab Syndr (2007) 0.99
Hypertension prevalence, awareness, control and association with metabolic abnormalities in the San Marino population: the SMOOTH study. J Hypertens (2006) 0.97
Metabolic syndrome and incident cardiovascular morbidity and mortality in a Mediterranean hypertensive population. Am J Hypertens (2007) 0.95
New treatment strategies for patients with hypertension and insulin resistance. Am J Med (2006) 0.93
Acute coronary syndromes in Europe: 1-year costs and outcomes. Curr Med Res Opin (2007) 0.93
Relation of the first hypertension-associated event with medication, compliance and persistence in naïve hypertensive patients after initiating monotherapy. Int J Clin Pharmacol Ther (2010) 0.92
Prevalence, awareness, treatment and control of hypertension in Galicia (Spain) and association with related diseases. J Hum Hypertens (2007) 0.92
Prognostic relevance of metabolic syndrome in hypertensive patients at low-to-medium risk. Am J Hypertens (2007) 0.91
A national hypertension treatment program in Germany and its estimated impact on costs, life expectancy, and cost-effectiveness. Health Policy (2007) 0.89
Metabolic syndrome and left ventricular hypertrophy in a general population. Results from the Gubbio Study. J Hum Hypertens (2007) 0.89
Prehypertension is associated with insulin resistance state and not with an initial renal function impairment. A Metabolic Syndrome in Active Subjects in Spain (MESYAS) Registry substudy. Am J Hypertens (2006) 0.87
Modelling the costs of care of hypertension in patients with metabolic syndrome and its consequences, in Germany, Spain and Italy. Eur J Health Econ (2010) 0.84
The PANDORA project: results of the cost of illness analysis. J Hum Hypertens (2001) 0.84
Comparisons of hypertension-related costs from multinational clinical studies. Pharmacoeconomics (2004) 0.84
[Prevalence and general features of the metabolic syndrome in the Spanish hypertensive population]. Med Clin (Barc) (2006) 0.84
The metabolic syndrome predicts cardiovascular events in subjects with normal fasting glucose: results of a 15 years follow-up in a Mediterranean population. Atherosclerosis (2007) 0.83
Metabolic syndrome, organ damage and cardiovascular disease in treated hypertensive patients. The ERIC-HTA study. Blood Press (2007) 0.83
Cardiovascular risk profile and blood pressure control in Italian hypertensive patients under specialist care. J Hypertens (2004) 0.83
Undiagnosed obesity in hypertension: clinical and therapeutic implications. Blood Press (2007) 0.80
Should hypertension guidelines be changed for hypertensive patients with the metabolic syndrome? J Clin Hypertens (Greenwich) (2007) 0.80
Cost of hypertension in Spain. J Hum Hypertens (1992) 0.80
ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J (2011) 10.52
Renal damage in primary aldosteronism: results of the PAPY Study. Hypertension (2006) 4.20
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol (2006) 3.74
Short-term administration of dark chocolate is followed by a significant increase in insulin sensitivity and a decrease in blood pressure in healthy persons. Am J Clin Nutr (2005) 3.66
Cocoa reduces blood pressure and insulin resistance and improves endothelium-dependent vasodilation in hypertensives. Hypertension (2005) 3.26
Costs and consequences of large-scale vector control for malaria. Malar J (2008) 2.93
ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Atherosclerosis (2011) 2.90
Comparison of electronic data capture (EDC) with the standard data capture method for clinical trial data. PLoS One (2011) 2.06
Access to health care and mortality of children under 5 years of age in the Gambia: a case-control study. Bull World Health Organ (2009) 1.81
Distinct roles for FOXP3 and FOXP3 CD4 T cells in regulating cellular immunity to uncomplicated and severe Plasmodium falciparum malaria. PLoS Pathog (2009) 1.81
Blood pressure is reduced and insulin sensitivity increased in glucose-intolerant, hypertensive subjects after 15 days of consuming high-polyphenol dark chocolate. J Nutr (2008) 1.71
The effect of universal leukoreduction on postoperative infections and length of hospital stay in elective orthopedic and cardiac surgery. Transfusion (2004) 1.71
Innate immune responses to human malaria: heterogeneous cytokine responses to blood-stage Plasmodium falciparum correlate with parasitological and clinical outcomes. J Immunol (2006) 1.62
Effects of bezafibrate and simvastatin on endothelial activation and lipid peroxidation in hypercholesterolemia: evidence of different vascular protection by different lipid-lowering treatments. J Clin Endocrinol Metab (2003) 1.54
[Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation]. G Ital Cardiol (Rome) (2009) 1.52
ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Atherosclerosis (2011) 1.51
Comparison of two interferon gamma release assays in the diagnosis of Mycobacterium tuberculosis infection and disease in The Gambia. BMC Infect Dis (2007) 1.48
The aldosterone-renin ratio based on the plasma renin activity and the direct renin assay for diagnosing aldosterone-producing adenoma. J Hypertens (2010) 1.46
Within-patient reproducibility of the aldosterone: renin ratio in primary aldosteronism. Hypertension (2009) 1.45
Determinants of bed net use in the Gambia: implications for malaria control. Am J Trop Med Hyg (2007) 1.45
Cytokine and fibrogenic gene expression in the conjunctivas of subjects from a Gambian community where trachoma is endemic. Infect Immun (2004) 1.41
Soluble CD40 ligand is predictive of combined cardiovascular morbidity and mortality in patients on haemodialysis at a relatively short-term follow-up. Nephrol Dial Transplant (2011) 1.40
Long-term blood pressure changes induced by the 2009 L'Aquila earthquake: assessment by 24 h ambulatory monitoring. Hypertens Res (2013) 1.39
Body mass index predicts plasma aldosterone concentrations in overweight-obese primary hypertensive patients. J Clin Endocrinol Metab (2008) 1.38
Limitations and discrepancies of transthoracic and transoesophageal echocardiography compared with surgical findings in patients submitted to surgery for complications of infective endocarditis. J Cardiovasc Med (Hagerstown) (2006) 1.38
Elevated iron status strongly predicts mortality in West African adults with HIV infection. J Acquir Immune Defic Syndr (2007) 1.36
Controlled analysis of blood pressure sensitivity to sodium intake: interactions with hypertension type. J Hypertens (2003) 1.34
Long-term protection against HBV chronic carriage of Gambian adolescents vaccinated in infancy and immune response in HBV booster trial in adolescence. PLoS One (2007) 1.34
Is mosquito larval source management appropriate for reducing malaria in areas of extensive flooding in The Gambia? A cross-over intervention trial. Am J Trop Med Hyg (2010) 1.29
Endothelial cell activation in men with erectile dysfunction without cardiovascular risk factors and overt vascular damage. J Urol (2004) 1.29
Incidence of tuberculosis and survival after its diagnosis in patients infected with HIV-1 and HIV-2. AIDS (2004) 1.26
Cytomegalovirus infection in Gambian infants leads to profound CD8 T-cell differentiation. J Virol (2007) 1.26
The role of communication between clients and health care providers: implications for adherence to malaria treatment in rural Gambia. Trop Med Int Health (2007) 1.24
Optimizing odor-baited trap methods for collecting mosquitoes during the malaria season in The Gambia. PLoS One (2009) 1.23
Determinants of provider choice for malaria treatment: experiences from The Gambia. Soc Sci Med (2008) 1.23
A simple approach to test for interaction between intervention and an individual-level variable in community randomized trials. Trop Med Int Health (2008) 1.18
Conjunctival expression of matrix metalloproteinase and proinflammatory cytokine genes after trichiasis surgery. Invest Ophthalmol Vis Sci (2010) 1.16
Flavonoids, vascular function and cardiovascular protection. Curr Pharm Des (2009) 1.16
Increased expression of mRNA encoding interleukin (IL)-4 and its splice variant IL-4delta2 in cells from contacts of Mycobacterium tuberculosis, in the absence of in vitro stimulation. Immunology (2004) 1.15
Benefits in cognitive function, blood pressure, and insulin resistance through cocoa flavanol consumption in elderly subjects with mild cognitive impairment: the Cocoa, Cognition, and Aging (CoCoA) study. Hypertension (2012) 1.15
Modeling health impact of global health programs implemented by Population Services International. BMC Public Health (2013) 1.14
Conjunctival FOXP3 expression in trachoma: do regulatory T cells have a role in human ocular Chlamydia trachomatis infection? PLoS Med (2006) 1.13
Comparison of the captopril and the saline infusion test for excluding aldosterone-producing adenoma. Hypertension (2007) 1.13
Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction. Eur Heart J (2003) 1.10
Human conjunctival transcriptome analysis reveals the prominence of innate defense in Chlamydia trachomatis infection. Infect Immun (2010) 1.07
Association Between Inflammatory Bowel Disease and Vitamin D Deficiency: A Systematic Review and Meta-analysis. Inflamm Bowel Dis (2015) 1.06
Genetic determinants of nonmodulating hypertension. Hypertension (2003) 1.06
Blood pressure control in Italy: analysis of clinical data from 2005-2011 surveys on hypertension. J Hypertens (2012) 1.04
Alternative treatments for indoor residual spraying for malaria control in a village with pyrethroid- and DDT-resistant vectors in the Gambia. PLoS One (2013) 1.03
Maintenance of large subpopulations of differentiated CD8 T-cells two years after cytomegalovirus infection in Gambian infants. PLoS One (2008) 1.02
Pathway-focused arrays reveal increased matrix metalloproteinase-7 (matrilysin) transcription in trachomatous trichiasis. Invest Ophthalmol Vis Sci (2010) 1.02
Field testing of different chemical combinations as odour baits for trapping wild mosquitoes in The Gambia. PLoS One (2011) 1.01
Oxidative stress and endothelial dysfunction: say NO to cigarette smoking! Curr Pharm Des (2010) 1.01
Conjunctival chlamydial 16S ribosomal RNA expression in trachoma: is chlamydial metabolic activity required for disease to develop? Clin Infect Dis (2006) 1.01
Flavonoids: antioxidants against atherosclerosis. Nutrients (2010) 1.01
COX-2: friend or foe? Curr Pharm Des (2007) 1.00
Chronic hyperuricemia, uric acid deposit and cardiovascular risk. Curr Pharm Des (2013) 1.00
Black tea consumption dose-dependently improves flow-mediated dilation in healthy males. J Hypertens (2009) 0.99
Tea, flavonoids, and nitric oxide-mediated vascular reactivity. J Nutr (2008) 0.99
Meeting oxygen needs in Africa: an options analysis from the Gambia. Bull World Health Organ (2009) 0.97
Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone-producing adenoma. J Hypertens (2007) 0.96
Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty. Circulation (2003) 0.96
Abnormal aldosterone physiology and cardiometabolic risk factors. Hypertension (2013) 0.95
Cardiovascular risk and endothelial dysfunction: the preferential route for atherosclerosis. Curr Pharm Biotechnol (2011) 0.92
Renin gene polymorphism: its relationship to hypertension, renin levels and vascular responses. J Renin Angiotensin Aldosterone Syst (2011) 0.92
Protective effects of flavanol-rich dark chocolate on endothelial function and wave reflection during acute hyperglycemia. Hypertension (2012) 0.91
Early activation of vascular endothelial cells and platelets in obese children. J Clin Endocrinol Metab (2005) 0.91
Chocolate, lifestyle, and health. Crit Rev Food Sci Nutr (2009) 0.90
Autologous skeletal myoblast transplantation in patients with nonacute myocardial infarction: 1-year follow-up. J Thorac Cardiovasc Surg (2006) 0.90
Endothelial activation. Sliding door to atherosclerosis. Curr Pharm Des (2005) 0.90
Physician attitudes to blood pressure control: findings from the Supporting Hypertension Awareness and Research Europe-wide survey. J Hypertens (2011) 0.89
Tea, flavonoids, and cardiovascular health: endothelial protection. Am J Clin Nutr (2013) 0.89
The economic and quality-of-life burden of Crohn's disease in Europe and the United States, 2000 to 2013: a systematic review. Dig Dis Sci (2014) 0.89
Changes in viral load and HBsAg and HBeAg status with age in HBV chronic carriers in The Gambia. Virol J (2008) 0.88
Aldosterone dysregulation with aging predicts renal vascular function and cardiovascular risk. Hypertension (2014) 0.88
Blood pressure and cardiovascular risk: what about cocoa and chocolate? Arch Biochem Biophys (2010) 0.87
Lysine-specific demethylase 1: an epigenetic regulator of salt-sensitive hypertension. Am J Hypertens (2012) 0.87
Cocoa consumption dose-dependently improves flow-mediated dilation and arterial stiffness decreasing blood pressure in healthy individuals. J Hypertens (2015) 0.87
Prehypertension is associated with insulin resistance state and not with an initial renal function impairment. A Metabolic Syndrome in Active Subjects in Spain (MESYAS) Registry substudy. Am J Hypertens (2006) 0.87
2012 consensus document of the Italian Society of Hypertension (SIIA): strategies to improve blood pressure control in Italy: from global cardiovascular risk stratification to combination therapy. High Blood Press Cardiovasc Prev (2013) 0.86
Endothelium/nitric oxide mechanism mediates vasorelaxation and counteracts vasoconstriction induced by low concentration of flavanols. Eur J Nutr (2012) 0.86
Hypertension and migraine comorbidity: prevalence and risk of cerebrovascular events: evidence from a large, multicenter, cross-sectional survey in Italy (MIRACLES study). J Hypertens (2011) 0.85
Angiotensin II inhibits endothelial cell motility through an AT1-dependent oxidant-sensitive decrement of nitric oxide availability. Arterioscler Thromb Vasc Biol (2003) 0.85
Modelling the costs of care of hypertension in patients with metabolic syndrome and its consequences, in Germany, Spain and Italy. Eur J Health Econ (2010) 0.84
Are plasma biomarkers of immune activation predictive of HIV progression: a longitudinal comparison and analyses in HIV-1 and HIV-2 infections? PLoS One (2012) 0.84
Nonmodulation as the mechanism for salt sensitivity of blood pressure in individuals with hypertension and type 2 diabetes mellitus. J Clin Endocrinol Metab (2012) 0.84
Nonpharmacological treatment of hypercholesterolemia increases circulating endothelial progenitor cell population in adults. Arterioscler Thromb Vasc Biol (2006) 0.83
Are physicians underestimating the challenges of hypertension management? Results from the Supporting Hypertension Awareness and Research Europe-wide (SHARE) survey. Eur J Prev Cardiol (2012) 0.83
The burden of testosterone deficiency syndrome in adult men: economic and quality-of-life impact. J Sex Med (2007) 0.83
Angiotensin-converting-enzyme inhibition counteracts angiotensin II-mediated endothelial cell dysfunction by modulating the p38/SirT1 axis. J Hypertens (2013) 0.83
Vitamin E supplementation reduces plasma vascular cell adhesion molecule-1 and von Willebrand factor levels and increases nitric oxide concentrations in hypercholesterolemic patients. J Clin Endocrinol Metab (2002) 0.83